Current Report Filing (8-k)
November 15 2019 - 7:08AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported):
November 15, 2019
BIO-PATH HOLDINGS, INC.
(Exact name of registrant as specified
in its charter)
Delaware
|
001-36333
|
87-0652870
|
(State or other jurisdiction
of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
4710 Bellaire Boulevard, Suite 210, Bellaire, Texas
|
77401
|
(Address of principal executive offices)
|
(Zip Code)
|
(832) 742-1357
(Registrant’s Telephone Number, Including
Area Code)
(Former Name or Former Address, if Changed
Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨
|
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
|
Trading Symbol
|
|
Name of each exchange on which registered
|
Common Stock, par value $0.001 per share
|
|
BPTH
|
|
The Nasdaq Capital Market
|
|
|
|
|
|
Indicate by check mark whether the registrant is an
emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 2.02 Results of Operations and
Financial Condition.
The information in
this Current Report on Form 8-K (this “Current Report”) is being furnished pursuant to Item 2.02 of Form 8-K and, according
to general instruction B.2. thereunder, the information in this Current Report shall not be deemed “filed” for the
purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section.
The information in this Current Report shall not be incorporated by reference into any registration statement pursuant to the Securities
Act of 1933, as amended.
On November 15, 2019,
Bio-Path Holdings, Inc. (the “Company”) issued a press release announcing financial results for the quarter ended September
30, 2019. Additional information is included in the Company’s press release. A copy of the Company’s press release
is attached hereto as Exhibit 99.1. The foregoing description of the press release is qualified in its entirety by reference to
the attached exhibit.
Item
9.01 Financial Statements and Exhibits.
(d) Exhibits.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Company has duly caused this Current Report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
BIO-PATH HOLDINGS, Inc.
|
|
|
|
|
|
|
Dated: November 15, 2019
|
By:
|
/s/ Peter H. Nielsen
|
|
|
Peter H. Nielsen
|
|
|
President and Chief Executive Officer
|
EXHIBIT INDEX
Bio Path (NASDAQ:BPTH)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bio Path (NASDAQ:BPTH)
Historical Stock Chart
From Sep 2023 to Sep 2024